AC2993: Started Phase III trial

Amylin Pharmaceuticals Inc. (AMLN), San Diego, Calif.
Product: AC2993
Business: Metabolic
Therapeutic category: Metabolism

Read the full 149 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE